AVROBIO
AvroBio is a clinical-stage biopharmaceutical company developing cell and gene therapies to treat rare diseases. It is based in Cambridge, Massachusetts.
Last updated on
About AVROBIO
Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$285MCategory
Industry
BiotechnologyLocation
City
CambridgeState
MassachusettsCountry
United StatesAVROBIO
Find your buyer within AVROBIO